Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Gins4 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of GINS4 mRNA | CTD | PMID:28189721 and PMID:28960355 | 1,2-dimethylhydrazine | multiple interactions | ISO | Gins4 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GINS4 mRNA | CTD | PMID:22206623 | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of GINS4 mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Gins4 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of GINS4 mRNA | CTD | PMID:21570461 and PMID:24680724 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GINS4 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GINS4 mRNA | CTD | PMID:32109520 and PMID:34747641 | 2,4-diaminotoluene | increases expression | ISO | Gins4 (Mus musculus) | 6480464 | 2 and 4-diaminotoluene results in increased expression of GINS4 mRNA | CTD | PMID:20713471 | 3-methylcholanthrene | increases expression | ISO | Gins4 (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of GINS4 mRNA | CTD | PMID:20713471 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Gins4 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of GINS4 mRNA | CTD | PMID:18648102 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of GINS4 mRNA | CTD | PMID:30047161 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of GINS4 mRNA | CTD | PMID:31881176 | acrylamide | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of GINS4 mRNA | CTD | PMID:32763439 | aflatoxin B1 | affects expression | ISO | GINS4 (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of GINS4 protein | CTD | PMID:20106945 | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of GINS4 mRNA | CTD | PMID:23630614 and PMID:25378103 | aflatoxin B1 | increases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of GINS4 mRNA | CTD | PMID:21632981 and PMID:22100608 | all-trans-retinoic acid | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of GINS4 mRNA | CTD | PMID:33167477 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of GINS4 mRNA | CTD | PMID:30047161 | benzo[a]pyrene | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of GINS4 mRNA | CTD | PMID:22316170 | benzo[a]pyrene | increases methylation | ISO | GINS4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of GINS4 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | ISO | GINS4 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of GINS4 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of GINS4 mRNA | CTD | PMID:21632981 and PMID:32234424 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20018196 and PMID:26238291 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of GINS4 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Gins4 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of GINS4 mRNA | CTD | PMID:33221593 and PMID:35598803 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of GINS4 mRNA | CTD | PMID:32145629 | bisphenol A | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of GINS4 mRNA | CTD | PMID:29275510 | Bisphenol A diglycidyl ether | affects splicing | ISO | Gins4 (Mus musculus) | 6480464 | 2 and 2-bis(4-glycidyloxyphenyl)propane affects the splicing of GINS4 mRNA | CTD | PMID:36464114 | cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of GINS4 promoter | CTD | PMID:22457795 | cadmium dichloride | increases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of GINS4 protein | CTD | PMID:24527689 | cefaloridine | increases expression | EXP | | 6480464 | Cephaloridine results in increased expression of GINS4 mRNA | CTD | PMID:18500788 | chlordecone | decreases expression | ISO | Gins4 (Mus musculus) | 6480464 | Chlordecone results in decreased expression of GINS4 mRNA | CTD | PMID:29980752 | chlorpyrifos | decreases expression | ISO | Gins4 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of GINS4 mRNA | CTD | PMID:37019170 | cisplatin | increases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of GINS4 mRNA | CTD | PMID:27392435 and PMID:27594783 | cisplatin | multiple interactions | ISO | GINS4 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of GINS4 mRNA | CTD | PMID:27392435 | copper(II) sulfate | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of GINS4 mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | ISO | GINS4 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS4 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of GINS4 mRNA | CTD | PMID:20106945 more ... | dibutyl phthalate | decreases expression | ISO | Gins4 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of GINS4 mRNA | CTD | PMID:21266533 | dioxygen | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of GINS4 mRNA | CTD | PMID:26516004 | dorsomorphin | multiple interactions | ISO | GINS4 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GINS4 mRNA | CTD | PMID:27188386 | Enterolactone | multiple interactions | ISO | GINS4 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of GINS4 mRNA | CTD | PMID:19167446 | ethyl methanesulfonate | increases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of GINS4 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | ISO | Gins4 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of GINS4 mRNA | CTD | PMID:22206623 | formaldehyde | increases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of GINS4 mRNA | CTD | PMID:23649840 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of GINS4 mRNA | CTD | PMID:25539665 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of GINS4 mRNA | CTD | PMID:33387578 | indole-3-methanol | affects expression | EXP | | 6480464 | indole-3-carbinol affects the expression of GINS4 mRNA | CTD | PMID:21396975 | methidathion | increases expression | ISO | Gins4 (Mus musculus) | 6480464 | methidathion results in increased expression of GINS4 mRNA | CTD | PMID:34813904 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of GINS4 mRNA | CTD | PMID:30047161 | methyl methanesulfonate | increases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in increased expression of GINS4 mRNA | CTD | PMID:23649840 | niclosamide | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Niclosamide results in decreased expression of GINS4 mRNA | CTD | PMID:36318118 | ozone | multiple interactions | ISO | Gins4 (Mus musculus) | 6480464 | TTPA protein affects the reaction [Ozone results in increased expression of GINS4 mRNA] | CTD | PMID:19555225 | p-chloromercuribenzoic acid | increases expression | ISO | GINS4 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of GINS4 mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | ISO | GINS4 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GINS4 mRNA | CTD | PMID:27188386 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of GINS4 mRNA | CTD | PMID:33387578 | piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of GINS4 mRNA | CTD | PMID:22484513 | pirinixic acid | increases expression | ISO | Gins4 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of GINS4 mRNA | CTD | PMID:20813756 and PMID:23811191 | pregnenolone 16alpha-carbonitrile | increases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in increased expression of GINS4 mRNA | CTD | PMID:30047161 | quercetin | increases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Quercetin results in increased expression of GINS4 mRNA | CTD | PMID:21632981 | quinolin-8-ol | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Oxyquinoline results in decreased expression of GINS4 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | GINS4 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GINS4 mRNA | CTD | PMID:27188386 | sodium arsenite | increases expression | ISO | GINS4 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of GINS4 mRNA | CTD | PMID:34032870 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of GINS4 mRNA | CTD | PMID:30047161 | sunitinib | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of GINS4 mRNA | CTD | PMID:31533062 | testosterone | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of GINS4 mRNA | CTD | PMID:33359661 | tetrachloromethane | affects expression | ISO | Gins4 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of GINS4 mRNA | CTD | PMID:31919559 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of GINS4 mRNA | CTD | PMID:23411599 and PMID:34492290 | urethane | decreases expression | ISO | GINS4 (Homo sapiens) | 6480464 | Urethane results in decreased expression of GINS4 mRNA | CTD | PMID:28818685 | |